c-Met Is a Potentially New Therapeutic Target for Treatment of Human MelanomaNeelu Puri, Ravi Salgia|Clinical Cancer Research|2007Cited by 154
Alternative Signaling Pathways as Potential Therapeutic Targets for Overcoming EGFR and c-Met Inhibitor Resistance in Non-Small Cell Lung CancerJason Fong, Neelu Puri|PLoS ONE|2013Cited by 45
Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung CancerGregory M. Botting, Neelu Puri|PLoS ONE|2015Cited by 43
Mediating EGFR-TKI Resistance by VEGF/VEGFR Autocrine Pathway in Non-Small Cell Lung CancerChike Osude, Neelu Puri|Cells|2022Cited by 37
Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanomaRyan Fong, Neelu Puri|Oncotarget|2013Cited by 29